According to Seelos Therapeutics
's latest financial reports the company has a price-to-book ratio of -0.1458.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Year | P/B ratio | Change |
---|---|---|
2023-12-31 | -0.4063 | -94.08% |
2022-12-31 | -6.86 | -328.61% |
2021-12-31 | 3.00 | -91.02% |
2020-12-31 | 33.4 | -100.65% |
2019-12-31 | < -1000 | -245474.33% |
2018-12-31 | 2.11 | -67.08% |
2017-12-31 | 6.41 | -578.86% |
2016-12-31 | -1.34 | -73.35% |
2015-12-31 | -5.02 | -121.73% |
2014-12-31 | 23.1 | 154.77% |
2013-12-31 | 9.07 | 0.77% |
2012-12-31 | 9.00 | -59.92% |
2011-12-31 | 22.5 | 304.05% |
2010-12-31 | 5.56 | -49.68% |
2009-12-31 | 11.0 | 43.56% |
2008-12-31 | 7.69 | -68.67% |
2007-12-31 | 24.5 | 425.02% |
2006-12-31 | 4.68 | -94.02% |
2005-12-31 | 78.2 | 1050.24% |
2004-12-31 | 6.80 | -45.96% |
2003-12-31 | 12.6 | 101.91% |
2002-12-31 | 6.23 |
Company | P/B ratio | differencediff. | Country |
---|---|---|---|
ORIC Pharmaceuticals
ORIC | 2.89 | -2,083.54% | ๐บ๐ธ USA |